Browse studies, page 3
Page 3 of 1,159, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Antifungal Susceptibility Testing for Microsporum canis from Cats in Japan Medical Mycology Journal, 2023
- Constant Voltage Iontophoresis Technique to Deliver Terbinafine via Transungual Delivery System: Formulation Optimization Using Box–Behnken Design and In Vitro Evaluation Pharmaceutics, 2021
- Design, Synthesis, and Trypanosomicidal Evaluation of Eugenol-Based Azole Hybrids: Discovery of an In Vitro Active and Selective Compound ACS Omega, 2025
- Optimization of an in vitro drug screening assay for anti- Trypanosoma cruzi activity using epimastigotes Biology Methods and Protocols, 2026
- In Vitro and in Vivo Study of a Photostable Quinone Compound with Enhanced Therapeutic Efficacy against Chagas Disease Chemical and Pharmaceutical Bulletin, 2024
- The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo Medical Mycology, 2023
- Superior Anticancer and Antifungal Activities of New Sulfanyl-Substituted Niclosamide Derivatives Biomedicines, 2024
- Structure-activity relationships of 1,5-dihydro-2H-benzo[b][1,4]diazepine-2,4(3H)-diones as inhibitors of Trypanosoma cruzi RSC medicinal chemistry, 2025
- Sandalwood Oils of Different Origins Are Active In Vitro against Madurella mycetomatis, the Major Fungal Pathogen Responsible for Eumycetoma Molecules (Basel, Switzerland), 2024
- Synthesis and Anti-Trypanosoma cruzi Activity of New Pyrazole-Thiadiazole Scaffolds Molecules, 2024
- Treatments and the Perspectives of Developing a Vaccine for Chagas Disease Vaccines, 2024
- Neglected Tropical Diseases (NTD) in Worldwide and Its Significance in Health Care Services on Present Population International Journal of Science and Research (IJSR), 2023
- Antifungal Pharmacokinetics/Pharmacodynamics Medical Mycology Journal, 2026
- Optimization of 1,4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against Trypanosoma cruzi Molecules, 2021
- Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach Expert Opinion on Drug Discovery, 2022
- Trypanosoma cruzi persisters that survive benznidazole treatment in vitro and in vivo are in a transient non-replicative state bioRxiv (Cold Spring Harbor Laboratory), 2023
- Challenges in Chagas Disease Drug Development Molecules, 2020
- Assessment and management of Chagas disease: a comprehensive analysis International Journal of Pharmaceutical Research and Applications, 2025
- Trypanocidal Treatment for Chronic Chagas Disease: Past, Present, and Future Revista da Sociedade Brasileira de Medicina Tropical, 2025
- Design and feasibility of an implementation strategy to address Chagas guidelines engagement focused on attending women of childbearing age and children at the primary healthcare level in Argentina: a pilot study BMC Family Practice, 2022
- Efficacy and Safety of Chagas Disease Drug Therapy and Treatment Perspectives InTech eBooks, 2018
- T Cell Specificity: A Great Challenge in Chagas Disease Frontiers in Immunology, 2021
- Lippia origanoides Essential Oil or Thymol in Combination with Fluconazole Produces Damage to Cells and Reverses the Azole-Resistant Phenotype of a Candida tropicalis Strain Journal of Fungi, 2023
- Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice PLoS Pathogens, 2023
- Benznidazole Anti-Inflammatory Effects in Murine Cardiomyocytes and Macrophages Are Mediated by Class I PI3Kδ Frontiers in Immunology, 2021
- New Anti-Parasitic Agents, Trends and Trials 2025
- Candida Glabrata Produces a Melanin-Like Pigment that Protects Against Stress Conditions Encountered During Parasitism Future Microbiology, 2021
- Chagas Disease: Comparison of Therapy with Nifurtimox and Benznidazole in Indigenous Communities in Colombia Journal of Clinical Medicine, 2024
- New global targets for NTDs in the WHO roadmap 2021–2030 PLoS neglected tropical diseases, 2021
- The Escalating Specter of Antifungal Resistance in Superficial Mycoses Preprints.org, 2023
- A Novel Hyphal Suspension Approach for MIC Testing of Mould Fungi Mycoses, 2026
- New Therapeutics for Chagas Disease: Charting a Course to Drug Approval IntechOpen eBooks, 2022
- Tropical infectious diseases and the skin: Diagnostic and treatment updates since the WHO's integrated campaign against neglected tropical skin diseases Dermatological Reviews, 2023
- Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives ACS Omega, 2024
- Intra-host Trypanosoma cruzi strain dynamics shape disease progression: the missing link in Chagas disease pathogenesis Microbiology Spectrum, 2023
- In Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, a Potential Novel Compound for Treating against Trypanosoma cruzi Pathogens, 2022
- Metabolomic profiling for the identification of drug targets in trypanosomes Frontiers in Chemical Biology, 2026
- Chagas Disease: From Discovery to a Worldwide Health Problem Frontiers in Public Health, 2019
- Enteric nervous system regeneration and functional cure of experimental digestive Chagas disease with trypanocidal chemotherapy Nature Communications, 2024
- Fungi’s Swiss Army Knife: Pleiotropic Effect of Melanin in Fungal Pathogenesis during Cattle Mycosis Journal of Fungi, 2023
- Possibility of re-purposing antifungal drugs posaconazole & isavuconazole against promastigote form of Leishmania major The Indian Journal of Medical Research, 2024
- Chagas Disease Drug Discovery in Latin America—A Mini Review of Antiparasitic Agents Explored Between 2010 and 2021 Frontiers in Chemistry, 2021
- Drug repurposing for Chagas disease: In vitro assessment of nimesulide against Trypanosoma cruzi and insights on its mechanisms of action PLoS ONE, 2021
- Structure-Guided Design and Synthesis of a Pyridazinone Series of Trypanosoma cruzi Proteasome Inhibitors Journal of Medicinal Chemistry, 2023
- Sandalwood Sesquiterpene (Z)-α-Santalol Exhibits In Vivo Efficacy Against Madurella mycetomatis in Galleria mellonella Larvae Molecules, 2025
- The translational challenge in Chagas disease drug development Memórias do Instituto Oswaldo Cruz, 2022
- Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease Pharmaceutics, 2022
- Advancing topical posaconazole delivery: BOX behnken design microsponge hydrogel optimization and extensive in vivo investigation International Journal of Applied Pharmaceutics, 2024
- Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure PLoS neglected tropical diseases, 2022
- Pyrazole-Imidazoline Derivative Prevents Cardiac Damage and Mortality in Acute Trypanosoma cruzi Infection Pharmaceuticals, 2025
- Preclinical data do not support the use of amiodarone or dronedarone as antiparasitic drugs for Chagas disease at the approved human dosing regimen Frontiers in Tropical Diseases, 2023
- Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases? Frontiers in Cellular and Infection Microbiology, 2022
- Mechanisms of resistance against allylamine and azole antifungals in Trichophyton: A renewed call for innovative molecular diagnostics in susceptibility testing PLoS Pathogens, 2025
- Perspectives for a new drug candidate for Chagas disease therapy Memórias do Instituto Oswaldo Cruz, 2022
- The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in Africa Medical Mycology, 2023
- Localized cardiac small molecule trajectories and persistent chemical sequelae in experimental Chagas disease Nature Communications, 2023
- Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain Pathogens, 2021
- Screening of synthetic 1,2,3-triazolic compounds inspired by SRPIN340 as anti-Trypanosoma cruzi agents Revista da Sociedade Brasileira de Medicina Tropical, 2024
- A profile of research on the parasitic trypanosomatids and the diseases they cause PLoS neglected tropical diseases, 2022
- Precision Health for Chagas Disease: Integrating Parasite and Host Factors to Predict Outcome of Infection and Response to Therapy Frontiers in Cellular and Infection Microbiology, 2020
- Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease European Journal of Medicinal Chemistry, 2022
- Antifungal Combinations against Candida Species: From Bench to Bedside Journal of Fungi, 2022
- Amiodarone and Ravuconazole Combination Potentiates Chemotherapy against Drug-Resistant Trypanosoma cruzi Strains ACS Omega, 2025
- Short-course combination treatment for experimental chronic Chagas disease Science Translational Medicine, 2023
- In vitro susceptibility testing for black grain eumycetoma causative agents Transactions of the Royal Society of Tropical Medicine and Hygiene, 2020
- Bioactivity of Novel Pyrazole-Thiazolines Scaffolds against Trypanosoma cruzi: Computational Approaches and 3D Spheroid Model on Drug Discovery for Chagas Disease Pharmaceutics, 2022
- IID432, a parasite-selective topoisomerase II inhibitor, achieves rapid single-dose parasite clearance in a murine chronic Chagas model Proceedings of the National Academy of Sciences, 2026
- Antitrypanosomal Activity of 1,2,3-Triazole-Based Hybrids Evaluated Using In Vitro Preclinical Translational Models Biology, 2023
- Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy PLoS neglected tropical diseases, 2023
- Pharmacokinetic-pharmacodynamic modeling of benznidazole and its antitrypanosomal activity in a murine model of chronic Chagas disease PLoS neglected tropical diseases, 2025
- P4 COVID19-associated fungal infections Medical Mycology, 2022
- Global health initiatives and mycetoma management: the unmet promise Transactions of the Royal Society of Tropical Medicine and Hygiene, 2025
- S5.1b Antifungal r esistance Medical Mycology, 2022
- Topical Antifungal Therapy Combined with Nail Abrasion for the Treatment of Dermatophytoma: Single-Center Results — A Secondary Publication Dermatological Health, 2024
- Epidemiology, clinical features, and outcome of the hospitalized patients with Kerion in Fars Province, Iran: an eleven-year retrospective study BMC Pediatrics, 2024
- Antifungal susceptibility pattern of Candida isolated from cutaneous candidiasis patients in eastern Guangdong region: A retrospective study of the past 10 years Frontiers in Microbiology, 2022
- Case Report: Reactivation of Chagas disease in a patient with advanced HIV 15 Years after migration Frontiers in Tropical Diseases, 2025
- Assessing antibody decline after chemotherapy of early chronic Chagas disease patients Parasites & Vectors, 2021
- Parasitemia and antibody response to benznidazole treatment in a cohort of patients with chronic Chagas disease Frontiers in Parasitology, 2023
- In Vitro Ravuconazole Susceptibility of Anthropophilic Dermatophyte Strains Isolated from Japanese Patients Japanese Journal of Infectious Diseases, 2019
- Distribution and antifungal susceptibility profiles of candida species isolated from dermatomycosis patients Journal of Health Sciences and Medicine, 2024
- What Can Imaging Do for Mycetoma in an Immunocompetent Patient in Temperate Region Journal of Radiology Case Reports, 2025
- Population pharmacokinetic modeling of benznidazole in Brazilian patients with chronic Chagas disease Revista do Instituto de Medicina Tropical de São Paulo, 2022
- Why the mycetoma patients are still neglected PLoS neglected tropical diseases, 2022
- Combating Multidrug-Resistant Acinetobacter baumannii: Insights from Japan, with Global Relevance Dove Medical Press (Taylor and Francis Group), 2025
- Tinea capitis in Older Adults: A Neglected and Misdiagnosed Scalp Infection—A Systematic Review of Reported Cases Antibiotics, 2025
- Pyrazoline-Based Molecules In Antimicrobial Research: A Systematic Review International Journal of Environmental Sciences, 2025
- Impact of antiparasitic therapy on cardiovascular outcomes in chronic Chagas disease. A systematic review and meta-analysis EClinicalMedicine, 2024
- Screening for Trypanosoma cruzi infection in immigrants and refugees: Systematic review and recommendations from the Spanish Society of Infectious Diseases and Clinical Microbiology Eurosurveillance, 2020
- Use of benznidazole to treat chronic Chagas disease: An updated systematic review with a meta-analysis PLoS neglected tropical diseases, 2022
- Fungal Melanonychia: A Systematic Review Microorganisms, 2024
- Nail dystrophy caused by infectious skin diseases: a narrative review Journal of Korean Medical Association, 2025
- Ring of Fire: The Global Rise of Drug Resistant Ringworm and the Race to Outpace It: A Narrative Review of Dermatophytosis and Emerging Antifungal Resistance INDIAN JOURNAL OF ALLIED HEALTH SCIENCE, 2026
- WHF IASC Roadmap on Chagas Disease Global heart, 2020
- Experimental and Clinical Treatment of Chagas Disease: A Review The American journal of tropical medicine and hygiene, 2017
- Onychomycosis: An Updated Review Recent patents on inflammation & allergy drug discovery, 2020
- Phaeohyphomycosis in China Frontiers in cellular and infection microbiology, 2022
- Challenges and recent progress in drug discovery for tropical diseases Nature, 2018
- Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates Biomolecules, 2023
- Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States PLoS neglected tropical diseases, 2019
